Compare Research Peptide Blends: Wolverine, GLOW, KLOW, & CJC + Ipamorelin
Research peptide blends differ in their components and labeled amounts. This comparison covers four Vertex Labs listings: Wolverine, GLOW, KLOW and CJC-1295 No DAC + Ipamorelin. Use the table to identify each formulation, then review the individual product page and its batch documentation.
Research peptide blends like Wolverine, GLOW, KLOW, and CJC-1295 No DAC + Ipamorelin from Vertex Labs are formulated with distinct components and varying labeled amounts to target specific research objectives. These blends are designed to offer researchers different combinations of peptides, allowing for tailored experimental applications based on their unique compositions.
Compare components and labeled vial amounts
| Blend | Components per vial | Total labeled amount |
|---|---|---|
| Wolverine: BPC-157 + TB-500 | BPC-157 5 mg + TB-500 5 mg | 10 mg |
| GLOW | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg | 70 mg |
| KLOW | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg | 80 mg |
| CJC-1295 No DAC + Ipamorelin | CJC-1295 No DAC 5 mg + Ipamorelin 5 mg | 10 mg |
These figures describe the listed formulations. A batch report may show separate measured results. Match the selected product, lot and reported units before comparing either set of figures.
Wolverine vs GLOW vs KLOW
Wolverine contains BPC-157 and TB-500, with 5 mg of each. GLOW lists 10 mg of each of those components plus 50 mg GHK-Cu. KLOW has the same labeled component amounts as GLOW and adds 10 mg KPV. The differences involve both composition and total vial amount.
For the identities of the individual materials, see TB-500 vs BPC-157, what is GHK-Cu? and what is KPV?
Where the CJC-1295 No DAC + Ipamorelin blend differs
This is a separate two-component formulation. Its 10 mg total consists of 5 mg CJC-1295 No DAC and 5 mg Ipamorelin. It does not contain BPC-157, TB-500, GHK-Cu or KPV, and it is not the CJC-1295 with DAC product.
Read Ipamorelin vs CJC-1295 for the distinction between individual compounds, DAC status and a combined formulation.
How to review documentation for a blend
- Confirm the complete component list and the labeled amount of each component.
- Find the report for the blend and lot in the COA directory.
- Check what the report actually identifies or measures, including whether results are component-specific.
- Clarify any information required for your laboratory project that the report does not provide.
A report for an individual component does not verify a finished blend. Nor does a report for one blend or lot verify another. Consult the testing standards alongside the individual documents.
Frequently asked questions
Does a higher total milligram amount make one blend better?
Total labeled mass does not establish biological activity, suitability or performance. The relevant question is whether the exact material and its documentation match the laboratory project’s requirements.
Can research on individual peptides establish blend effects?
Not by itself. Findings about an individual component should remain attributed to that component and the study conditions. This composition table does not establish synergy, therapeutic effects or equivalence between formulations.
Are these names guaranteed to describe identical blends across suppliers?
Use each supplier’s actual component listing and report rather than assuming a shared commercial name guarantees the same formulation. This table describes the linked Vertex Labs listings.
Research use only. All listed materials are intended for laboratory research, not human consumption or veterinary use. This comparison provides no dosing, administration or reconstitution instructions.